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Abstract
Background:  Development of the eye depends partly on the periocular mesenchyme
derived from the neural crest (NC), but the fate of NC cells in mammalian eye development
and the signals coordinating the formation of ocular structures are poorly understood.
Results: Here we reveal distinct NC contributions to both anterior and posterior
mesenchymal eye structures and show that TGF  signaling in these cells is crucial for normal
eye development. In the anterior eye, TGF 2 released from the lens is required for the
expression of transcription factors Pitx2 and  Foxc1 in the NC-derived cornea and in the
chamber-angle structures of the eye that control intraocular pressure. TGF  enhances Foxc1
and induces Pitx2 expression in cell cultures. As in patients carrying mutations in PITX2 and
FOXC1, TGF  signal inactivation in NC cells leads to ocular defects characteristic of the human
disorder Axenfeld-Rieger’s anomaly. In the posterior eye, NC cell-specific inactivation of TGF 
signaling results in a condition reminiscent of the human disorder persistent hyperplastic
primary vitreous. As a secondary effect, retinal patterning is also disturbed in mutant mice.
Conclusions: In the developing eye the lens acts as a TGF  signaling center that controls the
development of eye structures derived from the NC. Defective TGF  signal transduction
interferes with NC-cell differentiation and survival anterior to the lens and with normal tissue
morphogenesis and patterning posterior to the lens. The similarity to developmental eye
disorders in humans suggests that defective TGF  signal modulation in ocular NC derivatives
contributes to the pathophysiology of these diseases.
BioMed  Central
Journal
of Biology
Open Access
Published: 14 December 2005
Journal of Biology 2005, 4:11
The electronic version of this article is the complete one and can be
found online at http://jbiol.com/content/4/3/11
Received: 23 May 2005
Revised: 19 September 2005
Accepted: 7 November 2005
© 2005 Ittner et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal of Biology 2005, 4:11Background
Normal functioning of the eye is dependent on a variety of
highly specialized structures in the anterior segment of the
eye. These include the cornea and lens, which are necessary
for light refraction; the iris, which protects the retina from
excess light; and the ciliary body and ocular drainage struc-
tures, which provide the aqueous humor required for
cornea and lens nutrition and for the regulation of intraocu-
lar pressure (Figure 1a-e). Development of these tissues
involves coordinated interactions between surface and
neural ectoderm and periocular mesenchyme that is derived
from the neural crest (NC). Failure of these interactions
results in multiple developmental eye disorders, such as
Axenfeld-Rieger’s anomaly, which consists of small eyes
(microphthalmia), hypoplastic irises, polycoria (iris tears),
and abnormal patterning of the chamber angle between the
cornea and the iris; it is also associated with a high preva-
lence of glaucoma [1]. 
Development of the anterior eye segment depends on the
proper function of two transcription factors in the periocu-
lar mesenchyme, the forkhead/winged-helix factor FOXC1
and the paired-like homeodomain factor PITX2. In humans,
hypomorphic and overactivating mutations in either gene
leads to Axenfeld-Rieger’s anomaly [1], and mutation of
either Foxc1 or Pitx2 in mice results in defective anterior eye-
segment formation, similar to that seen in human Axenfeld-
Rieger’s anomaly [2-4]. Whereas downstream targets of
FOXC1 expressed in the eye are supposedly involved in
modulating intraocular eye pressure and ocular develop-
ment [5], PITX2 target genes have been associated with
extracellular matrix synthesis and stability [6]. In contrast,
the upstream regulators of both FOXC1 and PITX2 remain
to be determined. Moreover, the identity of cells expressing
FOXC1 and PITX2 during anterior eye patterning is unclear.
It is conceivable that aberrant development of mesenchymal
NC cells contributes to the malformations observed in
Axenfeld-Rieger’s anomaly. Indeed, portions of the anterior
eye segment, including corneal endothelial cells, collagen-
synthesizing keratocytes, and iris melanocytes, were pro-
posed to originate from the NC [7-9]. The definite
contribution of NC, however, has been debated, as most of
the data comes from avian models in which ocular develop-
ment appears to be slightly different from that in mammals
[10]. Moreover, mechanisms controlling ocular NC migra-
tion and differentiation remain to be elucidated. 
Transforming growth factor   (TGF ) is a candidate factor
for the control of ocular NC-cell development. TGF  signal-
ing is required for the generation of many different non-
neural derivatives of the NC [11]. Interestingly, TGF 
signaling during eye development is critical, as ligand inacti-
vation and overexpression lead to defective ocular develop-
ment in mice [12,13]. In both cases normal development of
the anterior eye segment is affected, possibly as a result of
impaired NC migration and/or differentiation. In particular,
the phenotype upon disruption of the Tgfb2 gene recapitu-
lates certain features observed in Foxc1 and  Pitx2 mutant
mice. The cellular role of TGF  signaling in ocular NC
development is unknown, however, and a link between
TGF  signaling and activation of the transcription factors
FoxC1 and Pitx2 in ocular development has not yet been
established [12].
We report here the results of in vivo cell-fate mapping to
define in detail the contribution of the NC to the forming
eye in mice. In addition, we used conditional gene targeting
to inactivate TGF  signaling in NC stem cells and, as a
result, in ocular NC derivatives in order to assess the actions
of  TGF  on these cells during eye development. 
Results
Neural-crest cells contribute to multiple structures
derived from the eye mesenchyme
NC-cell-specific constitutive expression of  -galactosidase
in  transgenic mice allows monitoring of NC-cell migration
and fate during development in vivo [9,14]. This approach
was used in the present study to define the ocular struc-
tures originating from the NC. Rosa26 Cre reporter
(Rosa26R) mice, which express  -galactosidase following
Cre-mediated recombination, were mated with transgenic
mice expressing Cre recombinase under the control of the
Wnt1 promoter. Although Wnt1 is not expressed in any
structure of the developing eye (see Additional data file 1
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Figure 1 (see figure on the following page)
Neural crest (NC)-derived cells contribute to ocular development. (a) Toluidine blue staining of an adult eye. The boxed areas correspond to 
(b) a detailed view of the corneal assembly, including outer epithelium, stroma, and inner endothelium, and (c) the chamber angle at the
irido-corneal transition which includes the trabecular meshwork (tm). (d-j) In vivo fate mapping of NC-derived,  -galactosidase ( Gal)-expressing
cells (blue) reveals (d) the NC origin of corneal keratocytes (arrows) and of corneal endothelium (arrowhead). (e) Structures of the chamber angle,
including the trabecular meshwork are seen to be NC-derived. (f) At E10, the optic cup is surrounded by NC-derived cells expressing  Gal. 
(g-i) The majority of the cells in the periocular mesenchyme (arrows), which forms the anterior eye segment, are of NC origin, as assessed from
E11.5 to E13.5. (j) The primary vitreous at E13.5 (arrowheads) shows a strong NC contribution.http://jbiol.com/content/4/3/11 Journal of Biology 2005, Volume 4, Article 11 Ittner et al.  11.3
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Figure 1 (see legend on the previous page)
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expressed in the dorsal neural tube, allowing Wnt1-Cre-
mediated recombination in virtually all NC stem cells
[11,15]. In Wnt1-Cre/Rosa26R double transgenic mice,
 -galactosidase-expressing NC-derived cells can be visual-
ized by X-gal staining. 
NC-derived cells have previously been proposed to con-
tribute to ocular development in mice after embryonic day
(E)12 [10]. Interestingly, we found that NC-derived cells
were already detectable at E10 surrounding the optic cup
and the lens vesicle (Figure 1f). Until E13.5 (Figure 1f-j), the
NC-derived cells were found predominantly in the periocu-
lar mesenchyme, whereas the overlying epithelium, the
lens, and the retina were consistently X-gal-negative. In
addition, we observed that structures of the primary vitre-
ous, located between the lens and the retina, are NC-derived
(Figure 1f-j). At later stages (Figure 1d,e), X-gal-positive cells
contributed to corneal stroma and endothelium and to
structures of the chamber angle at the junction between the
cornea and the iris. In mature eyes, the stroma of the iris,
the ciliary body, and the trabecular meshwork, as well as
cells of the choroid and primary vitreous, are all of NC
origin (data not shown). Taken together, these results show
that NC-derived cells contribute to eye development as soon
as the eye vesicle is formed and, subsequently, to various
structures of the maturing eye.
Multiple ocular anomalies arise from inactivation of
TGF  signaling in NC-derived periocular mesenchyme 
The expression pattern of TGF  ligands and their receptors
during eye development was visualized by immunohisto-
chemistry at various developmental stages (E10.5 to E18),
showing that TGF 2 expression peaked in the forming lens
at E13.5 (Figure 2a) and E15, but decreased towards E18
(data not shown), whereas TGF 1 and TGF 3 were unde-
tectable (Additional data file 2 available with the online
version of this article and data not shown). At E13.5, TGF 
receptor type 2 (Tgfbr2) was expressed in periocular mes-
enchyme, lens, retina, and the primary vitreous (Figure 2b).
Because in vivo fate mapping revealed a substantial contri-
bution of the NC to the periocular mesenchyme, TGF  sig-
naling could be important for development of ocular NC
derivatives. We therefore analyzed the eyes of mouse
embryos after NC-specific inactivation of TGF  signaling
[11,16]. Tissue-specific signal inactivation was achieved by
Wnt1-Cre-mediated deletion of exon 4 of the Tgfbr2 gene
(Figure 2c), which leads to loss of Tgfbr2 protein expression
in NC stem cells [11]. In such Tgfbr2-mutant mice, both
Tgfbr2 expression (Figure 2d,f) and TGF -induced phos-
phorylation of the downstream signaling molecule Smad2
(pSmad2; Figure 2e,g) remained undetectable in the perioc-
ular mesenchyme. 
At E18, main structures of the anterior eye segment, including
the forming ciliary body, the iris and the trabecular mesh-
work, were all well defined in control animals; eye develop-
ment in the absence of TGF  signaling in NC-derived cells
was therefore analyzed first at E18. Most impressively, eyes
from Tgfbr2-mutant embryos were 26 ± 1% smaller than eyes
from control littermates (Figures 3a,4). The cornea in control
eyes was properly structured into epithelium and endo-
thelium covering a thick stroma, but in Tgfbr2-mutant mice
the cornea lacked an endothelial layer and no normal
stroma was formed (Figure 3b). In control mice, corneal
structures and the lens were clearly separated to form the
anterior eye chamber; in contrast, cornea and lens of Tgfbr2-
mutant eyes failed to separate, and no proper anterior eye
segment was built (Figure 3c). Moreover, normal formation
of the trabecular meshwork and the ciliary body, indicated
by a wrinkle in the iris primordium in control eyes, was not
observed in Tgfbr2-mutant eyes (Figure 3c). In addition, eye
sections from E18 Tgfbr2-mutant embryos revealed a remark-
able accumulation of cells between lens and retina, whereas
vessels of the hyaloid vascular system were present in corre-
sponding structures of control eyes (Figure 3d). Finally, the
retina of control mice was clearly structured into an inner
and an outer layer of cells, whereas the retina of Tgfbr2-
mutant mice showed diffuse patterning (Figure 3e). Thus,
Tgfbr2-mutant embryos show microphthalmic eyes with
anomalies of the anterior segment, similar to those seen in
human Axenfeld-Rieger’s anomaly, and the embryos also
had defects of the posterior eye segment.
Persistent hyperplastic primary vitreous in Tgfbr2-
mutant mice 
In normal mice, the primary vitreous, including the
hyaloid vascular system, persists until postnatal day (P)30.
Its regression starts postnatally around P14 to form the
avascular and transparent secondary vitreous [17]. In
patients with congenital persistent hyperplastic primary
vitreous, developmentally abnormal primary vitreous
becomes a fibro-vascular membrane, formed behind the
lens (retrolentally) [18]. Much as in human persistent
hyperplastic primary vitreous [19], irregular retrolental
structures present in Tgfbr2-mutant mice consisted of several
different cell types (Figure 5a-e). These included fibroblast-
like cells, prospective melanocytes expressing dopachrome
tautomerase mRNA (Dct; also called Trp-2; Figure 5c),
smooth muscle  -actin-positive pericytes (Figure 5b), and
vessels of the hyaloid vascular system (Figure 5e). Moreover,
staining with an antibody to Ki-67, a protein expressed only
in dividing cells, revealed proliferative cells in the retro-
lental tissue (Figure 5d).
Effects on the retina have been reported in patients with
persistent hyperplastic primary vitreous [20]. Moreover, as
11.4 Journal of Biology 2005, Volume 4, Article 11 Ittner et al.                                                 http://jbiol.com/content/4/3/11
Journal of Biology 2005, 4:11http://jbiol.com/content/4/3/11 Journal of Biology 2005, Volume 4, Article 11 Ittner et al.  11.5
Journal of Biology 2005, 4:11
Figure 2
Inactivation of TGF  signaling in ocular NC-derived cells. (a,b) TGF  ligand and receptor expression in the developing eye at E13.5. (a)
Immunoreactive TGF 2 (red) is predominantly expressed in the lens, whereas (b) Tgfbr2 immunostaining (brown) shows a broad expression of the
receptor in the forming eye, including the periocular mesenchyme, lens, primary vitreous, and retina. (c) Strategy used for Cre/loxP-mediated deletion
of exon 4 of the Tgfbr2 locus in NC stem cells (NCSC). Exon 4 (red), encoding the transmembrane domain and the intracellular phosphorylation
sites of the Tgfbr2 protein, is flanked by loxP sites (triangles) and deleted in NCSCs upon breeding with Wnt1-Cre mice. (d-g) A detailed view of the
forming anterior eye segment (box in b). (d) Strong expression of Tgfbr2 (brown) in the prospective chamber angle, corneal stroma and endothelium
can be seen in control embryos. (f) After deletion of Tgfbr2 in NCSC, Tgfbr2 is undetectable in corresponding structures. Moreover, defective TGF 
signaling in these structures is also reflected by the absence of phosphorylated (p) Smad2 in (g) Tgfbr2 mutant (open arrowheads) as compared with
(e) control embryos (arrowheads). 
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12 3 5 6 7instructive signals from the lens promote normal patterning
of the retina [21], the irregular retrolental structures in
Tgfbr2-mutant mice might alter normal interaction between
the lens and the retina. To test whether retinal development
in Tgfbr2-mutant mice was affected, retinas from embryos of
different ages were immunohistochemically stained for
factors known to be expressed at distinct stages of develop-
ment [22]. At E15, the inner parts of the retina from control
mice strongly expressed the transcription factors Brn3A in
retinal ganglion cells and Pax6 in amacrine cells of the gan-
glion cell layers; in contrast, Tgfbr2-mutant embryos had
lower numbers of both Brn3A- and Pax6-positive retinal
cells (Figure 5f,g). Moreover, at E15 the number of cells pos-
itive in the TUNEL-staining procedure, which detects apop-
totic cells, was higher in the retinas of Tgfbr2-mutant
embryos than in those of control embryos (13.3 ± 2.5/5 µm
section (mutant) versus 5.6 ± 0.5 (control); p < 0.01; not
shown). At E18, expression of Brn3A, Pax6 and neurofila-
ments defines distinct layers of the developing retina in
control eyes (Figure 5h). In Tgfbr2-mutant mice, however,
patterning into cell layers was disturbed, and the thickness
of the retina was increased in the mutants (Figures 4,5h).
Eyes of Tgfbr2-mutant mice are therefore affected by anom-
alies similar to persistent hyperplastic primary vitreous and
by disturbed retinal patterning.
Expression of Foxc1 and Pitx2, which are both
implicated in Axenfeld-Rieger’s anomaly, is
dependent on TGF  in NC-derived ocular cells 
Anterior eye segment anomalies in Tgfbr2-mutant mice were
reminiscent of human Axenfeld-Rieger’s anomaly (Figure
3). In vivo fate mapping revealed that migration of TGF -
dependent NC cells to the corneal stroma, the endothelium,
and the trabecular meshwork was unaffected in Tgfbr2-
mutant mice (Figure 6a). This indicates that the ocular mal-
formations arise from impaired differentiation rather than
from NC-cell migration defects. Interestingly, the anomalies
observed in the Tgfbr2-mutant embryos recapitulate aspects
of ocular defects found in Foxc1-null or Pitx2-null mice [2,3].
Loss of TGF  responsiveness in the cells of the periocular
mesenchyme might therefore affect expression of the tran-
scription factors Foxc1 and Pitx2. To test this hypothesis, we
analyzed eyes from Tgfbr2-mutant and control embryos at
different developmental stages for the presence of Foxc1 and
Pitx2. We confirmed previous reports [2,23] that the two
factors are expressed in the periocular mesenchyme during
early development (Figure 6b and data not shown); at E15,
however, Foxc1 localizes to the corneal endothelium and
structures of the forming trabecular meshwork (Figure 6d),
and Pitx2 to the corneal stroma (Figure 7a). In contrast, in
eyes of Tgfbr2-mutant embryos Foxc1 was hardly detectable
in the periocular mesenchyme at E13.5 and in the forming
chamber angle and corneal endothelium at E15. Moreover,
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Figure 3
Compound ocular anomalies in Tgfbr2-mutant mice. (a) Toluidine blue
staining of semi-thin sagittal sections of eyes at E18 reveals a smaller
size with no anterior chamber and an infiltration of cells behind the lens
in Tgfbr2-mutant embryos as compared with control embryos. Boxes
indicate magnified regions shown in the other panels; scale bars
represent 250  m. (b) Abnormal corneal stroma in Tgfbr2-mutant
embryos. (c) Structures of the forming chamber angle, including the
trabecular meshwork (black arrowhead) in control eyes are absent in
Tgfbr2-mutant eyes (open black arrowhead). Here, the lens and the
cornea fail to separate to form the anterior eye chamber (open arrow).
In addition, dark-field images (insets) visualizing the pigment of the
forming iris (broken line in the main image) reveal initiation of ciliary-
body formation (white arrowheads) in control eyes and its absence in
Tgfbr2-mutant eyes (open white arrowheads). (d) In control eyes, the
primary vitreous consists of loosely arranged vessels of the hyaloid
vascular system (arrows). In contrast, Tgfbr2-mutant mice show a dense
cell mass between the lens and the retina (asterisk), reminiscent of
human persistent hyperplastic primary vitreous. (e) The retina of
control eyes displays typical patterning, with clear separation into an
inner layer (IRL) and an outer layer (ORL). In Tgfbr2-mutant mice,
however, there is no apparent patterning of the retina.
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(e)Tgfbr2-mutant cells that failed to express Foxc1 appeared to
subsequently undergo apoptosis around E15, as revealed by
TUNEL staining (Figure 6e).
Pitx2 was strongly expressed in the corneal stroma at E15
in control eyes, but was undetectable in the eyes of Tgfbr2-
mutant embryos (Figure 7a). Interestingly, some Tgfbr2-
mutant cells of the corneal stroma expressed Dct rather
than Pitx2, pointing to incorrect fate acquisition towards
melanocytes or misguidance during migration (Figure 7b).
At E18, the corneal stroma of control embryos consisted of
thin keratocytes organized in a lamellar structure and
embedded in extracellular matrix, which provides corneal
stability and transparency (Figure 7c). High levels of colla-
gen were detectable in the corneal stroma of control mice,
whereas collagen staining was negative in the malformed
cornea of E18 Tgfbr2-mutant mice, and stromal cells had
an abnormal polygonal shape (Figure 7c,d). In summary,
NC-derived ocular cells that lack responsiveness to TGF 
fail to express Foxc1 and Pitx2 and fail to undergo correct
differentiation into corneal endothelial cells and collagen-
synthesizing keratocytes of the corneal stroma.
TGF    induces Foxc1 and Pitx2 expression in
fibroblasts and in ex vivo eye cultures 
The absence of Foxc1 and Pitx2 expression in the develop-
ing eyes of Tgfbr2-mutant mice raises the question of
whether TGF  signaling can regulate the expression of
Foxc1 and/or Pitx2. To address this issue, cultured rat
embryonic fibroblasts were treated with TGF  and ana-
lyzed by western blot for the presence of Foxc1 and Pitx2
(Figure 8a). In the absence of TGF , the cells showed weak
expression of Foxc1, and Pitx2 expression was undetectable.
TGF  treatment, however, strongly increased Foxc1 expres-
sion and induced Pitx2 expression, concomitant with
increased levels of pSmad2 (Figure 8a). In addition to
fibroblasts, postmigratory NC-derived cells of mouse peri-
ocular mesenchyme were also responsive to TGF , as shown
in short-term tissue cultures of eyes from E11 embryos
(Figure 8b): again, treatment with TGF  resulted in elevated
Foxc1 expression. Moreover, Pitx2 expression, which was
undetectable in untreated samples, was induced upon addi-
tion of TGF . In summary, TGF  treatment upregulates
both Foxc1 and Pitx2 expression in a fibroblast cell line and
in embryonic eye tissue cultures. TGF  signaling is therefore
not only required for the expression of transcription factors
associated with developmental eye disorders, but it is also
sufficient to regulate their expression.
Discussion 
This study demonstrates that targeted inactivation of TGF 
signaling in NC stem cells perturbs proper development of
NC-derived structures in the eye, leading to malformations
similar to those found in human Axenfeld-Rieger’s anomaly
and persistent hyperplastic primary vitreous. The impor-
tance of inductive signals from the lens for correct develop-
ment of the anterior eye segment as well as for retinal
patterning has previously been proposed [21,24]. Mutation
in genes causing lens anomalies and subsequent abnormal
eye formation has further supported this hypothesis
[25,26]. Here, we propose that one of the key signaling
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Figure 4
Impaired ocular growth in Tgfbr2-mutant mice leads to microphthalmia. (a) The developing eyes and (b-e) eye compartments of Tgfbr2-mutant and
control embryos are of comparable size at E13.5, but subsequently, the eyes of Tgfbr2-mutant mice are smaller than controls. (c) The growth of the
lens is comparable, but (b) the thickness of the cornea and (d) vitreous (measured as the distance between the lens and the optic-nerve disc) are
drastically decreased in Tgfbr2-mutant mice. (e) In contrast, the thickness of the retina is increased in the mutant. For each time point, mid-organ
sagittal sections of both eyes were analyzed for at least three mice.
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(a) Eye (b) Cornea (c) Lens (d) Vitreous (e) Retinamolecules involved in these processes is TGF 2, which is
highly expressed in the lens at early stages of eye develop-
ment. Among the signal-receiving cell types, NC-derived
cells have a major role in ocular development. According to
earlier studies in avian models, NC cells contribute to the
developing anterior eye segment [27]. Using in vivo fate
mapping of NC cells, we have extended these findings to a
mammalian model and demonstrate that NC-derived cells
contribute to the forming eye as early as the eye vesicle
stage. Later, the corneal endothelium, stromal keratocytes
and structures of the chamber angle all originate from the
NC. In addition, we found a contribution of NC to the
primary vitreous, which normally contains a transient
network of vessels that supports the inner eye during devel-
opment. Intriguingly, all these NC-derived tissues fail to
develop properly in the absence of TGF  signaling,
although NC-cell migration into the forming eye remains
unaffected (Figure 9). Moreover, we show that transcription
factors implicated in anterior eye development are targets of
TGF  signaling. Thus, our data indicate that ocular anom-
alies in mutant mice are due to the absence of a post-migra-
tory response of NC-derived cells to ocular TGF .
NC-cell-specific TGF    signal inactivation leads to
defects of the posterior eye segment 
The primary vitreous is situated directly behind the lens
and contains the hyaloid vascular system beneath NC-
derived cells. Normally, the primary vitreous regresses
during postnatal eye maturation through tissue remodeling
by apoptosis and phagocytosis, thereby generating the
avascular, transparent secondary vitreous [17]. In patients
suffering from persistent hyperplastic primary vitreous, a
dense cell membrane persists between the lens and the
retina. This congenital disorder is often accompanied by
cataracts, secondary glaucoma, and a variable degree of
microphthalmia [18,28]. Similarly, the primary vitreous in
the eyes of Tgfbr2-mutant mice appears as a dense cellular
membrane, and mutant eyes are smaller than those in
control mice. Much as in human persistent hyperplastic
primary vitreous [19], the persistent retrolental cell mass in
Tgfbr2-mutant mice contains fibroblast-like cells, pigmented
cells, and vessels of the hyaloid vascular system, and prolif-
erating cells are also seen. 
Other mouse mutants have been reported to have a pheno-
type similar to persistent hyperplastic primary vitreous,
including those mutant for the Arf1, Bmp4, or  p53 genes
[29-31]. In these models, normal postnatal regression of the
primary vitreous fails, resulting in a variable degree of anom-
alies reminiscent of persistent hyperplastic primary vitreous.
Similarly, a dense cell mass in the posterior eye has also
been observed previously in Tgfb2 null mice, but this was
not analyzed further [12]. Treatment of pregnant mice with
retinoic acid, which is known to interfere with TGF  signal-
ing [32], induces anomalies similar to persistent hyperplastic
primary vitreous in the offspring [33]. Thus, we conclude
that TGF  signaling in NC-derived cells constituting the
primary vitreous is important for tissue morphogenesis.
In the posterior eye segment, retinal development is also
disturbed upon ablation of Tgfbr2 in NC cells, separately
from the generation of persistent hyperplastic primary vitre-
ous. In particular, we observed increased retinal apoptosis at
E15 and abrogated retinal patterning, as shown by histology
and layer-specific tissue marker expression (Figure 5f-h).
Because there is no NC contribution to the retina, this
phenotype is probably due to a secondary, non-cell-
autonomous effect. The dense persistent primary vitreous in
Tgfbr2-mutant mice might conceivably constrain instructive
signals from the lens to the retina, but such putative signals
remain to be identified.
TGF    signal-dependent transcription factors and the
generation of Axenfeld-Rieger’s anomaly 
In addition to the defects reminiscent of persistent hyper-
plastic primary vitreous, all Tgfbr2-mutant mice have several
developmental defects in the anterior eye. The anterior
chamber of the eye is absent in the mutant because the
cornea and the lens fail to separate. Furthermore, normal for-
mation of the ciliary body and of the chamber angle with the
trabecular meshwork requires TGF  signaling, as these struc-
tures are defective in the mutant mice. The abnormalities
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Figure 5 (see figure on the following page)
Persistent hypertrophic primary vitreous and disturbed retinal patterning in Tgfbr2-mutant mice. (a) Detailed view of the persistent hypertrophic
primary vitreous in E18 Tgfbr2-mutant mice, showing a dense retrolental cell mass. (b-d) Staining shows that this mass is composed of various cell
types, including (b) smooth muscle  -actin (SM A)-positive pericytes (red) and (c) prospective melanocytes expressing Dct mRNA (blue). (d) Ki67
staining indicates cell proliferation (brown). (e) The persistent hypertrophic primary vitreous contains vessels of the hyaloid vascular system.
(f) Expression of Brn3A and Pax6 (red antibody staining) is readily detectable at E15 in the inner retinal layers of control eyes (top). In Tgfbr2-mutant
eyes, however, cells expressing these markers are less frequent. (g) Bar graph of the results shown in (f). Asterisks indicate a significant difference
(p < 0.001). (h) At E18, staining for Brn3A, Pax6, and neurofilaments (NF) reveals the expected patterning of the retina in control eyes and a diffuse
distribution in Tgfbr2-mutant embryos. Thus, retinal patterning is disturbed in Tgfbr2-mutant embryos with persistent hypertrophic primary vitreous.
Scale bars represent 10  m.http://jbiol.com/content/4/3/11 Journal of Biology 2005, Volume 4, Article 11 Ittner et al.  11.9
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*presented by Tgfbr2-mutant mice are characteristic of the
disorders found in patients with Axenfeld-Rieger’s anomaly
[10]. In this disorder, anterior segment dysgenesis impairs
the regulation of the intraocular pressure, which frequently
leads to developmental glaucoma. 
Other mouse mutants have also been implicated as models
for developmental anterior eye disorders. Mice homozygous
for an inactivating mutation of Pax6, a candidate for human
Peter’s anomaly, lack eyes [7]. Heterozygous Pax6+/- mice
have defects in the anterior eye segment, although less severe
than those found in Tgfbr2-mutant mice [34,35]. The expres-
sion of Pax6 in eyes of Tgfbr2-mutant mice is not affected,
however (data not shown), suggesting that their defects do
not depend on Pax6 modulation. In human Axenfeld-
Rieger’s anomaly, mutations have been found in the genes
encoding the transcription factors FOXC1 and PITX2 [1].
Deletion of either Foxc1 or Pitx2 in mice [2,3] leads to defects
in the anterior eye segment, very similar to those in Tgfbr2-
mutant mice described in this study. In the eye, Foxc1 is
expressed in the forming corneal stroma and endothelium
and, at later stages, in the structures of the prospective trabec-
ular meshwork [2]. Intriguingly, these structures express
Foxc1 in a TGF  signal-dependent manner, and Tgfbr2-
mutant prospective corneal endothelial and trabecular mesh-
work cells undergo apoptosis that is not observed in control
eyes. Furthermore, TGF  upregulates Foxc1 expression in
fibroblasts and cultured eye tissue, in agreement with a pre-
vious report that described Foxc1 as a target gene of TGF  in
human cancer-cell lines [36]. Thus, the data suggest that
lens-derived TGF  signaling controls the survival and devel-
opment of the NC-derived periocular mesenchyme that gives
rise to corneal endothelium and trabecular meshwork by
regulating Foxc1 expression in these cells (Figure 9). 
Pitx2 is expressed predominantly in NC-derived corneal
stromal cells that become collagen-synthesizing keratocytes.
In Tgfbr2-mutant mice, however, corneal stromal cells do
not express Pitx2 and consequently fail to develop into
collagen-synthesizing keratocytes. Recently, mutations in the
human TGFBR2 gene have been reported to cause Marfan’s
syndrome, a disorder also associated with defective
extracellular-matrix synthesis [37]. Thus, we conclude that
corneal NC-derived cells must have TGF -dependent expres-
sion of Pitx2 and differentiation to become stromal kerato-
cytes that produce the collagen matrix (Figure 9). In support
of this hypothesis, Pitx2 expression is strongly induced in
fibroblasts and eye tissue upon TGF  signal activation. 
In Axenfeld-Rieger’s anomaly patients who have a disease-
linked mutation in the PITX2 gene, ocular anomalies appear
to be accompanied by additional defects, including tooth
abnormalities, redundant periumbilical skin, and heart
defects (all together referred to as Rieger’s syndrome) [1].
Apart from its expression in NC-derived cells of the forming
eye, Pitx2 is expressed in several other tissues during develop-
ment, including the teeth, umbilicus, and the heart [23]. In
contrast to the mesenchymal expression pattern in the eye, in
other organs the expression of Pitx2 is restricted to structures
that are not NC-derived, but these structures, and especially
the tooth anlagen, are surrounded by or are in close contact
with NC-derived cells [14]. Nevertheless, Tgfbr2-mutant
embryos show no defects in the tooth anlagen or umbilicus at
E18 (data not shown). Therefore, Pitx2-dependent anomalies
in  Tgfbr2-mutant mice appear to be restricted to the eyes,
although because of embryonic lethality we could not deter-
mine whether there are additional Pitx2-dependent defects at
a developmental stage later than E19.
We recently reported that inactivation of TGF  signaling in
NC stem cells also leads to cardiac and craniofacial defects
and parathyroid and thymic gland anomalies reminiscent of
human DiGeorge syndrome [11]. Moreover, depending on
the cellular context, TGF  promotes non-neural cell fates in
cultured NC cells [38,39]. Hence, together with the findings
from the present study, there is good evidence that TGF  is
a key modulator of non-neural differentiation of post-
migratory NC cells during development of multiple tissues,
including the eye.
Conclusion 
We have shown an extensive contribution of the NC to the
developing anterior eye segment and to the primary
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Tgfbr2-mutant mice lack corneal expression of the transcription factor Foxc1. (a) In vivo fate mapping at E15 ( Gal, blue) demonstrates that
NC-derived cells have correctly migrated into control and Tgfbr2-mutant eyes, contributing to corneal stroma and endothelium. (b) At E13.5, the
periocular mesenchyme of control eyes is positive for Foxc1 antibody staining (brown; arrowheads), whereas Foxc1 is undetectable in corresponding
structures of Tgfbr2-mutant eyes (open arrowheads). (c) No apoptotic cells are found in either control or Tgfbr2-mutant eyes at E13.5 by TUNEL
analysis (open arrowheads). (d) At E15, the eyes of control embryos show strong expression of Foxc1 (brown) in the forming trabecular meshwork
(arrow) and in corneal endothelial cells (arrowheads). In Tgfbr2-mutant eyes, NC-derived cells localize to the cornea, but Foxc1 is undetectable in
prospective endothelial cells (open arrowheads) and in the forming trabecular meshwork (open arrow). (e) At E15, cells that fail to express Foxc1 in
Tgfbr2-mutant eyes appear to undergo apoptosis, unlike in control eyes, as revealed by TUNEL analysis (red).http://jbiol.com/content/4/3/11 Journal of Biology 2005, Volume 4, Article 11 Ittner et al.  11.11
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Tgfbr2 mutantvitreous. Moreover, proper differentiation of NC-derived
ocular cells is TGF -dependent (Figure 9). Specifically, we
have shown that TGF  is involved in growth restriction of
the primary vitreous and consequently that Tgfbr2-mutant
mice suffer from persistent hyperplastic primary vitreous. In
the anterior eye segment, anomalies in Tgfbr2-mutant mice
are reminiscent of human Axenfeld-Rieger’s anomaly.
Ocular expression of Pitx2 and Foxc1, which when mutated
can cause Axenfeld-Rieger’s anomaly, is TGF -dependent,
suggesting that both transcription factors are involved in
mediating TGF  signaling in ocular cells during develop-
ment. Interestingly, a report of a family suffering from both
Axenfeld-Rieger’s anomaly and persistent hyperplastic
primary vitreous suggested a common linkage between
genes for Axenfeld-Rieger’s anomaly and persistent hyper-
plastic primary vitreous [40]. Thus, our findings may lead to
further understanding of the pathophysiology of Axenfeld-
Rieger’s anomaly and persistent hyperplastic primary vitreous.
Materials and methods
Generation of Tgfbr2-mutant mice  
The generation of mice used in this study has been
described before [9,11,16,41]. Briefly, loxP-sites for Cre-
mediated recombination were introduced into the mouse
Tgfbr2 locus flanking exon 4, which encodes the transmem-
brane domain and is an important part of the functional
intracellular domain of the Tgfbr2 protein. Mice expressing
the Cre recombinase under the control of the Wnt1 pro-
moter and heterozygous for this Tgfbr2 ‘floxed’ allele were
mated with mice homozygous for the floxed allele. Inacti-
vation of TGF  signaling in NC-derived cells was achieved
in embryos inheriting Wnt1-Cre and two Tgfbr2 floxed
alleles [11]. 100% of all mutant embryos had the pheno-
type described in this study, as assessed by the analysis of
at least three embryos per stage and staining condition. In
contrast, littermates lacking the Wnt1-Cre transgene or car-
rying a wild-type Tgfbr2 allele expressed Tgfbr2 normally
and did not exhibit any overt phenotype, thus serving as
control animals. Genotyping was performed as described
[11]. All animal experiments were performed on the
C57BL/6 background, which has never been associated
with genetic mutations causing retinal degeneration.
Fate mapping of ocular NC-derived cells in vivo
The  Rosa26 reporter (Rosa26R) mouse strain expresses
 -galactosidase following Cre-mediated recombination [41].
To define the distinct contribution of the NC during ocular
development,  Rosa26R mice were crossed with Wnt1-Cre
transgenic mice [9]. At least three whole embryos per stage
were stained with the  -galactosidase substrate 5-bromo-4-
chloro-3-indolyl- -D-galactopyranoside (X-gal; Sigma,
Buchs, Switzerland) and subsequently fixed in 4%
paraformaldehyde overnight at 4°C. Subsequently, embryos
were embedded in paraffin, sectioned at 7  m, and dewaxed
for mounting with DFX (Fluka, Buchs, Switzerland). Some
sections were counterstained with eosin (Fluka). 
Staining procedures 
Embedding, sectioning and staining procedures were per-
formed as described [11]. Briefly, the eyes of at least three
embryos per stage were stained with primary antibodies to
TGF 1, TGF 2, and TGF 3 (Santa Cruz Biotechnology Inc.,
Santa Cruz, USA), Tgfbr2 (Santa Cruz), pSmad2 (Cell Sig-
naling Technology Inc., Beverly, USA), Ki-67 (Lab Vision
(UK) Ltd, Newmarket, UK), Brn3A [42], Pax6 (Chemicon
International Inc., Temecula, USA), neurofilament (Chemi-
con), Foxc1 (Santa Cruz), Pitx2 [23], and GFAP (Sigma).
For visualization the ABC elite Kit (Vector Laboratories Inc.,
Burlingame, USA) with Metal enhanced DAB (Pierce
Biotechnology Inc., Rockford, USA) or AP substrate kit I
(Vector) as substrates was used. In situ hybridization with
digoxigenin-labeled riboprobes to Dct was performed as
described [9,15]. TUNEL assays were performed following
the manufacturer’s guidelines (Roche Diagnostics, Basel,
Switzerland). Standard protocols were used for tissue pro-
cessing of semi-thin sections and subsequent toluidine blue
staining [43]. The Van Gieson’s staining procedure was used
to visualize collagen formation in the cornea. 
Assessment of ocular growth 
At least three Tgfbr2-mutant and control embryos per stage
were embedded and sectioned. Mid-organ sagittal sections
of both eyes were measured using an Eclipse E600 micro-
scope (Nikon, Tokyo, Japan) equipped with a CCD camera
(Kappa, Gleichen, Germany) and the PicEd Cora software
version 8.08 (JOMESA, Munich, Germany).
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Figure 7 (see figure on the following page)
Absence of the transcription factor Pitx2 and of collagen formation in the corneal stroma of Tgfbr2-mutant mice. (a) At E15, Pitx2 expression, as
detected by immunohistochemistry (red; arrowheads) is restricted to corneal stromal cells in control animals but is undetectable in the
corresponding structures of Tgfbr2-mutant mice (open arrowheads). (b) In situ hybridization for Dct, which marks prospective melanocytes, reveals
atypical expression in the corneal stroma of Tgfbr2-mutant embryos (arrows). (c) High magnification of the corneal stroma shows the typical
appearance of thin keratocytes in a parallel orientation and a dense extracellular matrix in control eyes at E18. In contrast, the corneal stroma of
Tgfbr2-mutant embryos lacks extracellular matrix and has cells with large nuclei and a polygonal shape. (d) Van Gieson’s staining reveals normal
collagen matrix in the corneal stroma of control embryos (purple) that is absent in Tgfbr2-mutant embryos.http://jbiol.com/content/4/3/11 Journal of Biology 2005, Volume 4, Article 11 Ittner et al.  11.13
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Tgfbr2 mutantCulture experiments 
Rat embryonic fibroblasts (rat2 cell line; American Type
Culture Collection, Mannassas, USA) were cultured in
DMEM:F12 medium (Gibco/Invitrogen, Carlsbad, USA)
containing 10% fetal bovine serum (Sigma). Following a 60
min incubation in DMEM:F12 medium containing 0.1%
bovine serum albumin at 37°C, cells were treated with
TGF  (5 ng/ml) for 90 min at 37°C as described [11]. For
short-term tissue-culture experiments, the eyes with periocu-
lar tissue were removed from nine embryos at E11 by
microdissection. Left and right eyes were pooled separately
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Figure 9
Summary of the TGF -dependent development of anterior and
posterior ocular structures. (a) NC-derived cells (blue) contribute to
structures of the anterior eye segment and the primary vitreous (PV).
TGF  signaling is involved in the formation of the ciliary body (CB) and
the trabecular meshwork (TM), and in control of PV growth. Moreover,
normal PV development and/or TGF  signaling are important for
correct retinal patterning. (b) In the cornea, prospective stromal
keratocytes and endothelial cells are of NC origin. Here, TGF 
signaling is needed for the expression of the transcription factors Foxc1
and Pitx2 and for normal differentiation of NC-derived cells into
collagen-synthesizing stromal keratocytes. Moreover, in forming corneal
endothelial cells (and in the TM), expression of Foxc1 and cell survival
requires TGF  signaling. 
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Figure 8
TGF  regulates expression of Foxc1 and Pitx2. Western-blot analyses
of cultured cells were performed using the antibodies shown. (a) Rat
embryonic fibroblasts were treated with TGF , which results in
increased levels of phosphorylated (p)Smad2. Furthermore, TGF 
signaling enhances expression of Foxc1 and induces Pitx2 expression, as
revealed by western-blot analysis. (b) In ex vivo short-term tissue
culture of E11 mouse eyes, including periocular mesenchyme, TGF 
strongly upregulates both Foxc1 and Pitx2 expression. 
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(b)and kept in DMEM:F12 medium containing 0.1% bovine
serum albumin and antibiotics with and without TGF 
(5 ng/ml), respectively, for 6 h at 37°C. Western blot analy-
sis of rat embryonic fibroblast extracts and mouse eye tissue
extracts were carried out as described [44]. Primary anti-
bodies used were against Actin (Chemicon), pSmad2 (Cell
Signaling), Foxc1 (Santa Cruz) and Pitx2 [23]. Each experi-
ment was performed at least three times.
Statistics
Results are shown as mean ± standard error of the mean
(S.E.M.). Graphs and statistical analyses used Prism 4.01
(GraphPad Software Inc., San Diego, USA).
Additional data files
The following files are available with the online version of
this article: Additional data file 1, a figure showing the
absence of Wnt1 expression during eye formation; and
Additional data file 2, a figure showing the expression of
TGF  isoforms during eye formation.
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